Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6211239
SERIAL NO

09011323

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for treating or preventing breast cancer or leukemia in subjects in need of such treatment are provided which involve the administration of 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN), a retinoid which induces G.sub.0 /G.sub.1 arrest and apoptosis. These methods are useful for treatment of breast cancers which express or do not express estrogen receptors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C I R D GALDERMA)F-06560 VALBONNE

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fontana, Joseph A Ellicott City, MD 4 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation